The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Genitourinary Drugs market was valued at US$ 28510 million in 2023 and is anticipated to reach US$ 35930 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
North American market for Genitourinary Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genitourinary Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Genitourinary Drugs include Novartis AG and Genentech etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genitourinary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genitourinary Drugs.
Report Scope
The Genitourinary Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genitourinary Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genitourinary Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Novartis AG
- Genentech
Segment by Type
- Urologicals
- Hormonal Therapy
- Gynecological
- Anti-infectives
Segment by Application
- Prostate Cancer
- Ovarian Cancer
- Bladder Cancer
- Cervical Cancer
- Renal Cancer
- Erectile Dysfunction
- Urinary Tract Infections
- Urinary Incontinence & Overactive Bladder
- Sexually Transmitted Diseases
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genitourinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genitourinary Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Genitourinary Drugs Market Overview
1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Genitourinary Drugs Segment by Type
1.2.1 Global Genitourinary Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Urologicals
1.2.3 Hormonal Therapy
1.2.4 Gynecological
1.2.5 Anti-infectives
1.3 Genitourinary Drugs Segment by Application
1.3.1 Global Genitourinary Drugs Market Value by Application: (2024-2030)
1.3.2 Prostate Cancer
1.3.3 Ovarian Cancer
1.3.4 Bladder Cancer
1.3.5 Cervical Cancer
1.3.6 Renal Cancer
1.3.7 Erectile Dysfunction
1.3.8 Urinary Tract Infections
1.3.9 Urinary Incontinence & Overactive Bladder
1.3.10 Sexually Transmitted Diseases
1.4 Global Genitourinary Drugs Market Size Estimates and Forecasts
1.4.1 Global Genitourinary Drugs Revenue 2019-2030
1.4.2 Global Genitourinary Drugs Sales 2019-2030
1.4.3 Global Genitourinary Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Genitourinary Drugs Market Competition by Manufacturers
2.1 Global Genitourinary Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Genitourinary Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Genitourinary Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Genitourinary Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genitourinary Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genitourinary Drugs, Product Type & Application
2.7 Genitourinary Drugs Market Competitive Situation and Trends
2.7.1 Genitourinary Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genitourinary Drugs Players Market Share by Revenue
2.7.3 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genitourinary Drugs Retrospective Market Scenario by Region
3.1 Global Genitourinary Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Genitourinary Drugs Global Genitourinary Drugs Sales by Region: 2019-2030
3.2.1 Global Genitourinary Drugs Sales by Region: 2019-2024
3.2.2 Global Genitourinary Drugs Sales by Region: 2025-2030
3.3 Global Genitourinary Drugs Global Genitourinary Drugs Revenue by Region: 2019-2030
3.3.1 Global Genitourinary Drugs Revenue by Region: 2019-2024
3.3.2 Global Genitourinary Drugs Revenue by Region: 2025-2030
3.4 North America Genitourinary Drugs Market Facts & Figures by Country
3.4.1 North America Genitourinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Genitourinary Drugs Sales by Country (2019-2030)
3.4.3 North America Genitourinary Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genitourinary Drugs Market Facts & Figures by Country
3.5.1 Europe Genitourinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Genitourinary Drugs Sales by Country (2019-2030)
3.5.3 Europe Genitourinary Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genitourinary Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Genitourinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Genitourinary Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Genitourinary Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genitourinary Drugs Market Facts & Figures by Country
3.7.1 Latin America Genitourinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Genitourinary Drugs Sales by Country (2019-2030)
3.7.3 Latin America Genitourinary Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genitourinary Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Genitourinary Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Genitourinary Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Genitourinary Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genitourinary Drugs Sales by Type (2019-2030)
4.1.1 Global Genitourinary Drugs Sales by Type (2019-2024)
4.1.2 Global Genitourinary Drugs Sales by Type (2025-2030)
4.1.3 Global Genitourinary Drugs Sales Market Share by Type (2019-2030)
4.2 Global Genitourinary Drugs Revenue by Type (2019-2030)
4.2.1 Global Genitourinary Drugs Revenue by Type (2019-2024)
4.2.2 Global Genitourinary Drugs Revenue by Type (2025-2030)
4.2.3 Global Genitourinary Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Genitourinary Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Genitourinary Drugs Sales by Application (2019-2030)
5.1.1 Global Genitourinary Drugs Sales by Application (2019-2024)
5.1.2 Global Genitourinary Drugs Sales by Application (2025-2030)
5.1.3 Global Genitourinary Drugs Sales Market Share by Application (2019-2030)
5.2 Global Genitourinary Drugs Revenue by Application (2019-2030)
5.2.1 Global Genitourinary Drugs Revenue by Application (2019-2024)
5.2.2 Global Genitourinary Drugs Revenue by Application (2025-2030)
5.2.3 Global Genitourinary Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Genitourinary Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Genitourinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis AG Genitourinary Drugs Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Genentech
6.2.1 Genentech Corporation Information
6.2.2 Genentech Description and Business Overview
6.2.3 Genentech Genitourinary Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Genentech Genitourinary Drugs Product Portfolio
6.2.5 Genentech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genitourinary Drugs Industry Chain Analysis
7.2 Genitourinary Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genitourinary Drugs Production Mode & Process
7.4 Genitourinary Drugs Sales and Marketing
7.4.1 Genitourinary Drugs Sales Channels
7.4.2 Genitourinary Drugs Distributors
7.5 Genitourinary Drugs Customers
8 Genitourinary Drugs Market Dynamics
8.1 Genitourinary Drugs Industry Trends
8.2 Genitourinary Drugs Market Drivers
8.3 Genitourinary Drugs Market Challenges
8.4 Genitourinary Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
